TY - JOUR T1 - The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer JO - Journal of Pharmaceutical Policy and Practice UR - https://doi.org/10.1186/s40545-023-00529-0 PY - 2024/03/11 AU - Sharman Moser S AU - Tanser F AU - Siegelmann-Danieli N AU - Apter L AU - Chodick G AU - Solomon J ED - DO - DOI: 10.1186/s40545-023-00529-0 PB - Informa UK Limited VL - 16 IS - 1 SP - 22 Y2 - 2025/04/17 ER -